ECM Therapeutics
Warrendale, US · Delaware corporation
ECM Therapeutics is a regenerative medicine company that develops and manufactures therapeutic products derived from extracellular matrix (ECM), a naturally occurring material that influences cell behavior, controls inflammation, and supports tissue restoration after injury. Its platform is based on extracellular matrix science and an associated patent portfolio.
Founders & leadership
SB
Stephen BadylakScientific Leader
PF
Paul F. FaganExecutive
KC
Katie CollinsExecutive
CS
Christine SheehyExecutive
JD
Jenna DzikiNamed on SEC filing
GH
George HusseyNamed on SEC filing
LS
Lindsey SaldinNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$35.2M disclosed across 1 of 3 rounds · 2018–2025
▶$35.2MraisedOct 2025 · 190 investors · BiotechnologyRule 506(b)
▶$35.2MraisedOct 2025 · 190 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul F. FaganExecutive Officer, Director
- Katie CollinsExecutive Officer, Director
- Christine SheehyExecutive Officer
- Jenna DzikiExecutive Officer
- Stephen BadylakExecutive Officer, Director
- George HusseyExecutive Officer
- Lindsey SaldinExecutive Officer
- Offering amount
- $40M
- Amount sold
- $35.2M
- First sale
- May 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapOsmosis11 shared keywordsOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.
Abcam10 shared keywordsSupplier of protein research tools to life scientists. Publicly listed on the LSE following an IPO.
Danaher9 shared keywordsDanaher is a global science and technology company specializing in biotech, diagnostics, and life sciences with businesses that innovate in drug development, molecular diagnostics, genomic medicine, and bioprocessing to help advance human health. Operating through multiple strategic platforms and with nearly 63,000 employees, Danaher develops technologies and solutions for researchers, biopharmaceutical producers, and healthcare systems globally.
Companies competing with ECM Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does ECM Therapeutics do?
- ECM Therapeutics is a regenerative medicine company that develops and manufactures therapeutic products derived from extracellular matrix (ECM), a naturally occurring material that influences cell behavior, controls inflammation, and supports tissue restoration after injury. Its platform is based on extracellular matrix science and an associated patent portfolio.
- Who founded ECM Therapeutics?
- ECM Therapeutics was founded by Stephen Badylak.
- How much funding has ECM Therapeutics raised?
- ECM Therapeutics has disclosed $35.2M raised across 1 of its 3 known rounds.
- Where is ECM Therapeutics headquartered?
- ECM Therapeutics is headquartered in Warrendale, US.